ClinicalTrials.govpublic full text
RECTIFY-1: Neoadjuvant Botensilimab + Balstilimab in MSS/pMMR Early Rectal Cancer
early rectal cancer, stage i rectal cancer, microsatellite stable rectal carcinoma, non-operative management, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 840949
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.